Tag: phase 2/3 trial

U.S. trial tests ivonescimab for advanced biliary tract cancer

October 21, 2026

A National Cancer Institute-funded phase 2/3 trial will test ivonescimab plus chemotherapy against standard chemoimmunotherapy in U.S. patients with advanced ...

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Tag: phase 2/3 trial

U.S. trial tests ivonescimab for advanced biliary tract cancer

POPULAR NEWS

U.S. trial tests ivonescimab for advanced biliary tract cancer

Survey links religious practices to perceived benefit in Chinese schizophrenia outpatients

Genomic resistance predictions need biological context, review finds

Bacteriophages could help oncolytic viruses penetrate cold tumors

About

Follow us

Recent News

U.S. trial tests ivonescimab for advanced biliary tract cancer

Survey links religious practices to perceived benefit in Chinese schizophrenia outpatients

Genomic resistance predictions need biological context, review finds

Subscribe to Blog via Email

Welcome Back!

Retrieve your password